Electrochemotherapy of cutaneous metastases of melanoma - A case series study and systematic review of the evidence

Dermatologic Surgery

Volumn 37, Issue 6, 2011, Pages 816-824

  Kis, Erika ^a   Oláh, Judit ^a   Ócsai, Henriette ^a   Baltas, Eszter ^a   Gyulai, Rolland ^a   Kemény, Lajos ^a   Horvath, Andrea Rita ^a,b,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYTOSTATIC AGENT;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CASE STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; KAPOSI SARCOMA; LOW DRUG DOSE; MALE; MELANOMA; PENIS CANCER; PRIORITY JOURNAL; SKIN METASTASIS; SUBCUTANEOUS METASTASIS; SUBCUTANEOUS TISSUE TUMOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PALLIATIVE CARE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79959855798     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01951..x     Document Type: Article

References (40)

1. Marty M, Sersa G, Garbay JR, Gehl J, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 2006;4:3-13. (Pubitemid 44755131)
2. Snoj M, Cemazar M, Slekovec Kolar B, Sersa G. Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy: case report. Croat Med J 2007;48:345-9.
3. Quaglino P, Mortera C, Osella-Abate S, Barberis M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008;15:2215-22.
4. Campana LG, Mocellin S, Basso M, Puccetti O, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009;16:191-9.
5. Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001;53:1-10. (Pubitemid 32015625)
6. Miklavcic D, Corovic S, Pucihar G, et al. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl 2006;4:45-51. (Pubitemid 44666531)
7. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochem Biophys Acta 2000;1523:73-83.
8. Pucihar G, Kotnik T, Valic B, Miklavcic D, Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng 2006;34:642-52.
9. Mir LM. Bases and rationale of the electrochemotherapy. EJC Suppl 2006;4:38-44. (Pubitemid 44666530)
10. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727-33.
11. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995;55:3450-5.
12. Mir LM, Gehl J, Sersa G, Collins CG, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. EJC Supplements 2006;4:14-25. (Pubitemid 44755132)
13. Sersa G. The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses. EJC Suppl 2006;4:52-9. (Pubitemid 44666532)
14. Byrne CM, Thompson JF. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther 2006;6:671-8. (Pubitemid 44192884)
15. Mir LM, Glass LF, Sersa G, Teissié J, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998;77:2336-42. (Pubitemid 28263963)
16. Heller R, Jaroszeski M, Perrott R, Messina J, et al. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997;7:10-8. (Pubitemid 27110277)
17. Sersa G, Stabuc B, Cemazar M, Miklavcic D, et al. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000;6:863-7. (Pubitemid 30159341)
18. Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2005;31:1029-35. (Pubitemid 41671119)
19. Byrne CM, Thompson JF, Johnston H, Hersey P, et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res 2005;15:45-51. (Pubitemid 40354473)
20. A melanoma malignum ellátásáról. Az Egészségügyi Minisztérium szakmai protokollja (Treatment of melanoma malignum. Guideline of the Hungarian Health Ministry). 2007.
21. Domenge C, Orlowski S, Luboinski B, De Baere T, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996;77:956-63. (Pubitemid 26061292)
22. WHO. Handbook for reporting Results of Cancer Treatment. 1997.
23. Snoj M, Rudolf Z, Paulin-Kosir SM, Cemazar M, et al. Long lasting complete response in melanoma treated by electrochemotherapy. EJC Suppl 2006;4:26-8. (Pubitemid 44666526)
24. Cemazar M, Milacic R, Miklavcic D, Dolzan V, et al. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anti-cancer Drugs 1998;9:525-30. (Pubitemid 28346501)
25. Puc M, Corovic S, Flisar K, Petkovsek M, et al. Techniques of signal generation required for electropermeabilization. Survey of electropermeabilization devices. Bioelectrochemistry 2004;64:113-24.
26. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
27. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, et al. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991;27:73-6.
28. Glass LF, Pepine ML, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996;132:1353-7. (Pubitemid 26386624)
29. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148-57. (Pubitemid 28299641)
30. Rols MP, Bachaud JM, Giraud P, Chevreau C, et al. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000;10:468-74.
31. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristóbal-Martínez L, et al. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001;32:273-6. (Pubitemid 32611639)
32. Kubota Y, Tomita Y, Tsukigi M, Kurachi H, et al. A case of perineal malignant melanoma successfully treated with electrochemotherapy. Melanoma Res 2005;15:133-4. (Pubitemid 40637992)
33. Gaudy C, Richard MA, Folchetti G, Bonerandi JJ, et al. Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J Cutan Med Surg 2006;10:115-21. (Pubitemid 351517524)
34. Kaehler KC, Egberts F, Hauschild A. Electrochemotherapy in symptomatic melanoma skin metastases: intraindividual comparison with conventional surgery. Dermatol Surg 2010;36:1200-2.
35. Pavselj N, Bregar Z, Cukjati D, Batiuskaite D, et al. The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans Biomed Eng 2005;52:1373-81. (Pubitemid 41169530)
36. Colombo GL, Matteo SD, Mir LM. Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manage 2008;4:541-8. (Pubitemid 351712013)
37. Snoj M, Rudolf Z, Cemazar M, Jancar B, et al. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs 2005;16:345-8. (Pubitemid 40283951)
38. Shimizu T, Nikaido T, Gomyo H, Yoshimura Y, et al. Electrochemotherapy for digital chondrosarcoma. J Orthop Sci 2003;8:248-51. (Pubitemid 36460525)
39. Curatolo P, Mancini M, Ruggiero A, Clerico R, et al. Successful treatment of Penile Kaposi's Sarcoma with electrochemotherapy. Derm Surg 2008;34:839-43.
40. Snoj M, Cemazar M, Srnovrsnik T, Kosir SP, et al. Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. Tumori 2009;95:398-402.